Tatva Chintan Pharma Chem Ltd.

TATVA

Market Cap
₹2,576 Cr.
P/E
84.85

Tatva Chintan Pharma Chem Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
8.84%
3yr Average
20.2%
5yr Average
23.69%
Net Profit Margin
Latest
10.74%
3yr Average
16.75%
5yr Average
14.91%
ROCE
Latest
11.22%
3yr Average
22.4%
5yr Average
25.2%
Debt to Equity
Latest
0.33
3yr Average
0.38
5yr Average
0.57
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Total reactor capacity (kL)
      Source
    • Capacity Utilization - Chemicals - Reactor (%)
      Source
    Peer Comparison
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Tatva Chintan Pharma Chem Ltd.
    View the discussion on ValuePickr - ValuePickr
    Tatva Chintan: A Speciality Chemical Multibagger? - SOIC
    Understanding Tatva Chintan - Dr Prashanth Mishra
    Tatva Chintan Pharma Chem: Pre-IPO Call with Management - Trendlyne
    Tatva Chintan Pharma Chem IPO – Everything you need to know! - JST Investments
    Value Chain - Tatva Chintan - Value Educator
    Breaking Down the Cost of an EV Battery Cell - Visual Capitalist
    timeline